Antimycotic effect of 3-phenyllactic acid produced by probiotic bacterial isolates against Covid-19 associated

Ravikumar Lunavath1, Saddam Hussain Mohammad1, Kiran Kumar Bhukya1

  • 1Centre for Microbial and Fermentation Technology, Department of Microbiology, University College of Science, Osmania University, Hyderabad, India.

Plos One
|March 30, 2023
PubMed

Insights

Probiotic lactic acid bacteria (LAB) and their metabolite 3-phenyllactic acid show significant antifungal activity against Covid-19 associated mucormycosis (CAM) pathogens. This research highlights potential new strategies for preventing and treating CAM in immunocompromised patients.

Area of Science:

  • Microbiology
  • Immunology
  • Biochemistry

Background:

  • Covid-19 associated mucormycosis (CAM) is an emerging threat to immunocompromised individuals.
  • Probiotics and their metabolites offer a promising avenue for preventing and treating opportunistic fungal infections like CAM.

Purpose of the Study:

  • To assess the efficacy and safety of probiotic lactic acid bacteria (LAB) and their metabolites against CAM pathogens.
  • To identify and characterize LAB with antimicrobial and antifungal properties from various natural sources.

Main Methods:

  • Isolation and characterization of LAB from human milk, honey bee intestine, toddy, and dairy milk using 16S rRNA sequencing and MALDI TOF-MS.
  • Antimicrobial and antifungal activity assays against standard and pathogenic fungi, including Rhizopus sp. and Mucor sp.
  • Quantification and characterization of the antagonistic metabolite 3-phenyllactic acid (PLA) using HPLC and LC-MS.

Main Results:

  • Three LAB isolates (Lactobacillus pentosus BMOBR013, Lactobacillus pentosus BMOBR061, Pediococcus acidilactici BMOBR041) exhibited significant antifungal activity against CAM-associated fungi.
  • 3-Phenyllactic acid (PLA) was identified as the key antagonistic metabolite, with L. pentosus BMOBR013 producing the highest yield (0.441 g/L).
  • The minimum inhibitory concentration of PLA against Rhizopus sp. and Mucor sp. was determined to be 180 mg/ml.

Conclusions:

  • Probiotic LAB and their metabolite PLA demonstrate potent inhibitory effects against Covid-19 associated mucormycosis pathogens.
  • These findings support the development of probiotic-based strategies for the prevention and treatment of CAM.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
67
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
100
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
52